In addition, we determined the specific type of FLT3 mutation for each patient and analyzed if FLT3-ITD and FLT3-TKD differ in their impact on survival of DNMT3A-mutant AML patients from TCGA (Supplementary Table 1, Supplementary Fig. 6). The gene discussed is FLT3; the disease is acute myeloid leukemia.